Professional Documents
Culture Documents
Complications of
Hysteroscopic and
Uterine Resectoscopic
Surgery
MALCOLM G. MUNRO, MD, FACOG, FRCS,*w
and LEE A. CHRISTIANSON, MDw
*Department of Obstetrics and Gynecology, David Geffen School of
Medicine at UCLA; and w Department of Obstetrics and
Gynecology, Kaiser-Permanente, West Los Angeles Medical Center,
Los Angeles, California
Abstract: Adverse events associated with hystero- previously undergone hysteroscopic surgery may be-
scopic procedures are generally rare, but, with increas- have in unusual ways, at least in premenopausal
ing operative complexity, it is now apparent that they women who experience menstruation or who become
are experienced more often. There exists a spectrum of pregnant. Fortunately, better understanding of the
complications that relate to generic components of mechanisms involved in these adverse events, as well
procedures, such as patient positioning, anesthesia, as the use or development of a number of innovative
and analgesia, to a number that are specific to intra- devices, have collectively provided the opportunity to
luminal endoscopic surgery that largely comprise perform hysteroscopic and resectoscopic surgery in a
perforation and injuries to surrounding structures manner that minimizes risk to the patient.
and blood vessels. Whereas a number of endoscopic Key words: hysteroscopy, electrosurgery, complica-
procedures require the use of distending media, the tions, distending media, risk reduction
response of premenopausal women to excessive ab-
sorption of nonionic fluids used for hysteroscopy is
somewhat unique, and deserves special attention on
the part the surgeon. There is also an increasing
awareness of uncommon but problematic sequelae
related to the use of monopolar radiofrequency ute- Introduction
rine resectoscopes that involve thermal injury to the Hysteroscopy is the process of visualizing
vulva and vagina. Furthermore, the uterus that has the cervical canal and endometrial cavity
with an endoscope. When used only for
Correspondence: Malcolm G. Munro, MD, FACOG, diagnosis, the procedure is limited to vis-
FRCS, Department of Gynecologic Services, Kaiser-
Permanente, Los Angeles Medical Center, 4900 Sunset ualization with or without targeted sam-
Blvd, 3rd Floor, Los Angeles, CA. E-mail: pling. However, hysteroscopy is also used
mmunro@ucla.edu to guide the performance of a spectrum of
M.G.M. is a consultant to the following entities: Boston intrauterine surgical procedures that in-
Scientific Corp, Hologic Inc., Karl Storz Endoscopy
America. L.A.C. declares that there is nothing to clude adhesiolysis, metroplasty, myomec-
disclose. tomy, polypectomy, sterilization, and
www.clinicalobgyn.com | 765
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
766 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 767
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
768 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 769
the weight as possible is borne by the foot. systemic analgesics alone or in combina-
Time in classic lithotomy and Trendelen- tion are often called ‘‘conscious’’ sedation
burg positions should be minimized while and also will not be dealt with. Although
maintaining leg position at or below the regional anesthesia is infrequently used
level of the right atrium.8 for hysteroscopic procedures, a recent
For any of these adverse events, it is case series supports the use of low-dose
important to make a prompt diagnosis to spinal anesthesia as a feasible technique
minimize the risk of permanent and for operative hysteroscopy in women with
serious neurological injury. With com- high surgical risks.13 The reader is re-
partment syndrome, decompression tech- ferred to the recent American College of
niques can prevent both local and Obstetricians and Gynecologists guide-
systemic long-term sequelae. In the event lines on the subject.14
of a neurological injury, it is important to
introduce appropriate physical therapy Local Anesthesia
early to reduce the chance of long-term Local anesthetic agents may be adminis-
or permanent muscle atrophy, thereby tered by the surgeon to supplement the
facilitating the ultimate return of normal effect of systemic analgesia provided by
function. an anesthesiologist who can provide as-
sistance should adverse events occur.
However, in most office settings, locally
Anesthesia administered agents are the sole source of
anesthesia, and the surgeon is usually the
ADVERSE EVENTS only physician in the room. Despite these
Any surgical procedure performed under limitations, a broad spectrum of diagnos-
regional or general anesthesia has the tic and operative hysteroscopic proce-
potential for a spectrum of generic com- dures can be performed in an office
plications that, in some instances, can be setting using a multimodality approach
catastrophic. Allergy, systemic injection, to local anesthesia.15 Consequently, it is
and overdose comprise the main adverse incumbent on the surgeon to understand
events associated with the use of local the prevention and management of com-
anesthesia. plications related to these locally active
anesthetics.
BACKGROUND Locally active anesthetic agents are
generally either from the amino amide or
Regional and General Anesthesia amino ester class, the latter being modi-
It is beyond the scope of this section to fied versions of para-aminobenzoic acid
deal with the spectrum of complications (PABA). These agents alter neuronal de-
that relate to regional and general anes- polarization by blocking sodium channels
thesia. However, it is important for the in the cell membrane, most commonly
anesthesiologist to be aware of issues that those of sensory nerves, thereby prevent-
may be first appreciated from their per- ing transmission of the sensation of pain
spective. Included in this list are fluid to the higher neurons. In large part, these
overload and electrolyte disturbances agents are metabolized in the liver with a
and gas embolization with either room half-life that varies according to the spe-
air, the products of tissue vaporization, cific agent and a number of factors dis-
or distending gases such as carbon dioxide cussed below, but typically is in the range
(CO2). Each of these situations will be of 1.5 to 2 hours.
discussed later in this manuscript. Issues With judicious and careful use, serious
relating to the use of anxiolytics and adverse reactions to injectable anesthetics
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
770 Munro and Christianson
are uncommon, but they have been de- intravascular injection is avoided and by
scribed in relationship to high plasma not exceeding the maximum recom-
concentrations that are secondary to one mended doses (lidocaine, 4 mg/kg; mepi-
or a combination of: (1) inadvertent intra- vacaine, 3 mg/kg). The use of a
vascular injection; (2) excessive dose; and vasoconstrictor reduces the amount of
(3) delayed clearance/metabolism.16 The systemic absorption of the agent, almost
potential central nervous system side ef- doubling the maximum dose that can be
fects of high plasma levels include oral used.17 Complications of intravascular
paresthesias, tremor, dizziness, blurred injection or anesthetic overdose include
vision, and seizures and can culminate in allergy, neurological effects, and impaired
respiratory depression and apnea. Cardi- myocardial conduction.
ovascular side effects are those of direct Allergy is characterized by the typical
myocardial depression—bradycardia and symptoms of agitation, palpitations, pru-
potential cardiovascular collapse—an ad- ritus, coughing, shortness of breath,
verse event more commonly described in urticaria, bronchospasm, shock, and con-
association with bupivacaine. Allergic re- vulsions. Treatment measures include
actions are generally IgE mediated and administration of oxygen, isotonic intra-
are usually associated with the ester class venous fluids, intramuscular or subcuta-
of anesthetics, related to the immunoge- neous adrenaline, and intravenous
nicity of PABA. Amino amide anesthetics prednisolone and aminophylline.
do not contain PABA, a circumstance Cardiac effects related to impaired my-
that markedly reduces the risk of allergy, ocardial conduction include bradycardia,
making the amides by far the most com- cardiac arrest, shock, and convulsions.
monly used agents. Emergency treatment measures include
Topical agents can also be associated the administration of oxygen, intravenous
with adverse events, including systemic atropine (0.5 mg) and epinephrine, and the
absorption that may be facilitated when initiation of appropriate cardiac resusci-
the agent is applied to disrupted epithelial tation. The most common central nervous
surfaces. The local effects may be limited system manifestations are paresthesia of
to burning or stinging, whereas systemic the tongue, drowsiness, tremor, and con-
effects mirror those associated with inject- vulsions. Options for therapy include in-
able agents, although serious and severe travenous diazepam and respiratory
manifestations are extremely rare. support.
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 771
and will be discussed separately in the dilators, partial or total perforation may
section on gas embolism. result, thereby compromising completion
of the procedure itself. Even partial per-
BACKGROUND forations may set the stage for increased
It goes without saying that if the objective systemic absorption of distending media
lens of the hysteroscope cannot be placed that is the subject of a later section.
through the cervical canal into the endo-
metrial cavity, hysteroscopic procedures RISK REDUCTION, RECOGNITION,
cannot be accomplished. Dilation of the AND MANAGEMENT OF ACCESS-
cervix is frequently not necessary, de- RELATED ADVERSE EVENTS
pending in part on the parity of the wom- The risk of complications with access may
an and in part on the outer diameter of the be largely reduced by any of a number of
hysteroscopic system. However, in some preoperative or intraoperative measures.
instances, active dilation is required to If a stenotic cervix is anticipated, there
access the endometrial cavity. In such may be value in the use of preprocedure
circumstances, the cervix has the potential techniques to facilitate or initiate cervical
to be traumatized, which may result in dilation. One approach is the use of a
lacerations and bleeding that require sur- natural or synthetic laminaria tent, in-
gical repair. serted through the cervical canal 3 to 8
Access to the endometrial cavity may be hours before the procedure. However,
compromised by intrinsic anatomic varia- positioning of even a thin laminaria re-
tion, by acquired anatomic abnormalities quires at least some degree of cervical
of the cervical canal, or by suboptimal dilation for placement all the way through
technique. Acute version and/or flexion the internal cervical os, a feature that
of the uterus are anatomic circumstances frequently limits the utility of this ap-
that can set the stage for difficult access. proach. Furthermore, if laminaria are left
The cervix may also be stenotic relating to in place too long in the nonpregnant
one or a number of factors that include cervix (eg, >24 h), the cervix may over-
nulliparity, postmenopausal status, and dilate, which is particularly counterpro-
previous surgery, such as Cesarean section ductive for maintenance of the distending
or previous cervical procedures such as media.
cryotherapy, large loop excision, or tradi- Another approach is the use of pharma-
tional conization. The stenosis may man- cologic agents such as prostaglandin E1
ifest at the level of the exocervix, more (misoprostol) administered 12 to 24 hours
common with cervices that have been before the procedure. Misoprostol may be
treated with cryotherapy, or at the level administered by various routes and dos-
of the internal os, more frequently encoun- ages; the most commonly prescribed regi-
tered in the setting of a previous Cesarean mens are 400 mg orally, 400 mg sublingual,
section. Our experience is that access can or 200 mg vaginally. There exists high-qual-
be made difficult secondary to otherwise ity evidence demonstrating the efficacy of
asymptomatic large nabothian cysts or misoprostol in reducing the need for
leiomyomata that alter the path of the cervical dilation and the incidence of dila-
cervical canal. tion-related cervical trauma.19–21 Adminis-
If dilation of the cervix is required, the tration in close proximity to the procedure
most common approach is to use cervical may result in a suboptimal response, even if
dilators; either the tapered semirigid ‘‘os administered sublingually.22 It is important
finder’’ for exocervical stenosis or rigid to note that misoprostol may be ineffective
standard dilators for stenosis at the level as a cervical ripening agent in postmeno-
of the internal os. Particularly with rigid pausal women,21,23 however, the addition
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
772 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 773
At the end of the procedure, the cervix can enter the systemic circulation, partic-
should be inspected for laceration and ularly when myometrial dissection results
bleeding. Minor bleeding may be man- in the transection of larger veins. Patients
aged with tamponade and time, while can develop severe hyponatremia, right
larger tears, or those for which bleeding heart failure, and pulmonary and cerebral
is not managed successfully by manual edema with resulting neurological injury
pressure, may require the placement of a and potentially death. There is evidence
delayed absorbable suture. that cerebral edema may be detectable
with as little as 500 mL absorption into
the systemic circulation.29,30 Conse-
Distending Media quently, it is critical to take measures to
reduce the risk of systemic absorption, to
ADVERSE EVENTS monitor the volume of fluid absorbed,
Rarely, adverse reactions to selected dis- and to manage the patient promptly and
tending agents can be encountered and effectively if excess absorption is sus-
gas embolization may, in some instances, pected or detected.
be a serious complication. More com- Calculation of systemic absorption can
monly, especially with nonphysiological be complicated by a number of factors. It
distending media, fluid and electrolyte can be difficult to capture of all the media
disturbances may result from excess sys- that exits the uterus, including that which
temic absorption. Excessive absorption of may saturate the sterile drapes and/or fall
hypotonic fluids can result in fluid over- on the floor of the procedure or operating
load and hypotonic hyponatremia, which room. Furthermore, there is frequent in-
may cause permanent neurological com- consistency with the actual volume of
plications or death. media solutions packaged in large 3-L
bags that have a volume typically 3% to
BACKGROUND 6% more than that indicated on the la-
Distention of the endometrial cavity is bel.31 The amount of distending media
necessary to create a viewing space for absorbed is also related to the intracavi-
both visual diagnosis and for the perform- tary pressure, which when exceeds the
ance of surgical procedures. The media mean arterial pressure may facilitate ab-
choices include gaseous CO2, high-viscos- sorption into the systemic circulation.32
ity 32% Dextran 70, and a number of low-
viscosity fluids, including nonelectrolytic ISSUES RELATED TO TYPE OF
solutions of glycine, sorbitol, mannitol, DISTENDING MEDIA
and dextrose in water, and electrolyte-
containing isotonic solutions such as nor- CO2
mal saline (NS). For diagnostic and sim- CO2 gas can be used as a distending
ple procedures this is rarely a concern, medium for diagnostic hysteroscopy. The
however, during many operative proce- gas is transmitted to the endometrial cav-
dures these agents can gain access to the ity through the sheath of the hysteroscopic
systemic circulation, if and when the in- system that, in turn is attached to an
tegrity of the uterine venous circulation is insufflator specially designed for the pro-
breached. In the extreme, fluid overload cedure, with rubberized or other suitable
may occur, and with the use of nonphy- connective tubing. Although appropriate
siological fluids, electrolyte disturbances for diagnostic purposes, CO2 is unsuitable
typically result. both for operative hysteroscopy and for
It comes as a surprise to many how diagnostic procedures in the setting of
quickly large volumes of distending media endometrial bleeding because there is no
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
774 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 775
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
776 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 777
FIGURE 1. Automated fluid management systems (A). The system comprises a pump and a
mechanism for determining the amount of fluid absorbed by the patient. The pump both infuses
distending media and controls intrauterine pressure at a setting determined by the surgeon. (B),
This schematic shows the mechanism of action of an automated fluid management system. The
distending media (A) is placed on the pole while canisters for collecting evacuated fluid are
attached to a separately mounted collection platform that can weigh the contents (B). The
distending media is infused through tubing to the pump attached to the microprocessor-based
controller (C). The pump is then connected to the hysteroscopic system with tubing (D) that is
depicted here passing through the vagina and the cervix into the endometrial cavity. Fluid within
the endometrial cavity is evacuated via tubing (E) into the collecting canisters. Fluid that leaks
around the resectoscope into the vagina is captured either in a specially designed pouch (F), or, if
it falls on the floor by a floor mat, each of which are connected to the collecting canister with
tubing (G and H). The collection platform is electronically connected to the controller (C) and
provides a continuous measurement of the weight of the collected fluid that is converted to
volume by the microprocessor. The ‘‘volume in’’ of the infused fluid is measured either by a
peristaltic pump (pictured) or indirectly by the weight of the fluid lost from the platform. The
microprocessor subtracts the collected fluid (out) from the infused fluid (in) to calculate the fluid
balance—the net systemic absorption.
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
778 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 779
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
780 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 781
complete each case expeditiously, to re- however, the complication may be a result
spect predetermined intravasation limits, of the hysteroscopic or resectoscopic pro-
and for anesthesiology to recognize that cedure itself. Complete perforations are
such emboli could impact blood gas meas- generally thought to result in inability to
urements and cardiac monitor findings. distend the endometrial cavity, or, if the
The process of reducing the risk of air injury occurs following establishment of a
emboli is clearly multifactorial. Before working space, by otherwise unexplainable
inserting the hysteroscopic system into loss of distension. In either instance, the
the endometrial cavity, the tubing and surgeon is generally unable to continue the
hysteroscope should be purged of room procedure.
air even if the distention medium is CO2. When complete perforation occurs as a
The number of instrument exchanges result of dilation of the cervix, there are
should be minimized, as, for example, usually no other injuries. However, if the
each removal and reinsertion of the resec- uterus is perforated by a sharp hystero-
toscope provides an additional opportu- scopic instrument, or with the activated
nity for the piston-like action of the tip of a laser or an RF electrode, there is a
hysteroscope assembly to push air into risk for injury to the adjacent blood ves-
the systemic circulation.70 Finally, leaving sels or viscera. Without further measures,
the cervical canal open to the air may such injuries are frequently complicated
facilitate the access of room air to the by delayed diagnosis, which is a particular
systemic circulation, so a dilator or other problem for small bowel injury, where
occlusive instrument should always be left mortality is high.76,77 In rare cases, unrec-
in the canal following the process of ognized uterine perforation can present as
dilation. abdominal compartment syndrome sec-
ondary to irrigation fluid moving from
the uterine cavity into the peritoneal
Perforation space.78
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
782 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 783
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
784 Munro and Christianson
to uterine arteries or other vessels in the near the uterine isthmus, where RF va-
pelvis. porization or electrodessication techni-
ques should be considered.
PREVENTION, RECOGNITION, AND When intracavitary bleeding is encoun-
MANAGEMENT tered during resectoscopic procedures,
Anemic patients who have low tolerance temporary elevation of the intrauterine
for intraoperative blood loss can be ren- pressure may reduce the blood flow suffi-
dered amenorrheic before surgery with cient to improve operative visualization.
GnRH analogs, and, provided adequate This in turn allows targeting of a large
iron therapy, generally increase their pre- caliber ball electrode for compression that
operative hemoglobin and iron stores. If, is followed by electrosurgical desiccation.
for some reason, such a surgical delay is Intractable bleeding may respond to the
not feasible, preoperative blood transfu- injection of diluted vasopressin deep into
sion can be considered. Another consid- the cervical stroma, again in doses and
eration, particularly when planning techniques described previously.52 An-
operations that involve deep myometrial other approach to the management of
resection, is the preoperative collection intracavitary bleeding recognized at the
and storage of autologous blood. end of a procedure (often secondary to the
Arteriovenous malformations are rare, loss of intrauterine tamponade effect
and may be confused with leiomyomas. from the distending media) is the inflation
Should resection be attempted on such a of a 30-mL Foley catheter balloon or
vascular lesion, massive bleeding may en- similar tamponade device.80 Such bal-
sue. Consequently, should there be any loons can easily and safely be inflated to
suspicion that a focal lesion involving the 50 mL if deemed necessary.
myometrium is an arteriovenous malfor- Management of suspected intraperito-
mation; preoperative assessment with neal bleeding, secondary to perforation of
Doppler ultrasound or magnetic reso- the uterus, will require either laparoscopic
nance imaging is advised. evaluation or laparotomy depending on
The risk or extent of intraoperative the clinical situation. Again, detailed
bleeding may also be reduced by preoper- management of injury to major vessels is
ative administration of GnRH analogs beyond the scope of this paper.
and/or the intraoperative (just before cer-
vical dilation) injection of diluted vaso-
pressin into the cervical stroma in the
same concentrations, doses, and techni- Electrosurgery
ques described previously to reduce the
force of dilation.51 The duration of action ADVERSE EVENTS
of dilute vasopressin is about 20 minutes, Thermal injury can occur to intraperito-
thus repeat dosing as appropriate may be neal structures, especially bowel, if an
of value. It is important to avoid intra- activated electrode perforates the myome-
vascular injection and to advise the anes- trium. Such an injury could also occur
thesiologist in advance of such injections without actual perforation if bowel was
to facilitate recognition of rare but im- adherent to the serosal surface and deep
portant adverse events such as hyperten- myometrial electrosurgical techniques are
sion and bronchospasm. used. Injury may also occur at the site of
The risk for injury to the larger caliber, placement of the dispersive electrode if it
myometrial branches of the uterine artery is improperly placed or dislodged. Rarely,
can be reduced by limiting the depth of with monopolar instrumentation, current
resection in the lateral endometrial cavity diversion may occur causing injury to one
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 785
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
786 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 787
FIGURE 3. Current diversion and vulvar vaginal burns. A probable mechanism for vulvar and
vaginal burns is depicted. A, The external sheath contacts the entire surface of the cervical canal.
Current between the generator and the electrode (hatched line) that capacitatively couples to the
external sheath is prevented from forming a zone of high current density as it completes the
circuit with the dispersive electrode. However, in (B) the external sheath has been removed
preventing contact of the external sheath with the surface of the cervical canal. In this situation,
current coupled with the sheath will complete the circuit via the contact with the vagina, which, if
of sufficient low surface area, will allow generation of a zone of high current density that can
create an undesired electrosurgical effect.
The most obvious cause of direct cou- is the existence of tissue fragments, the
pling is a breech in the electrode’s insu- result of resection, that bridge the gap
lation that, when appropriately flexed, between the active electrode and internal
results in contact with the internal sheath and/or external sheaths.86 The risk of
or telescope with capacitative coupling capacitative coupling appears to be in-
(capacitative coupling is the transfer of creased with the use of high-voltage cur-
energy from one otherwise unconnected rents such as those that come from the
circuit to another by means of mutual ‘‘coagulation’’ side of ESUs.87 Capacita-
capacitance) completing the circuit with tive coupling is also more likely to occur if
the external sheath. However, another the surgeon keeps the electrode continu-
potential mechanism of direct coupling ously active while not in direct or near
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
788 Munro and Christianson
contact with tissue, or when there are myometrium. Even in selected instances,
continuing attempts to coagulate al- such as metroplasty or bulk vaporization
ready-desiccated tissue. of a leiomyoma, the electrode should
The key mechanism in the generation never be advanced unless it can be easily
of vulvar and vaginal thermal injuries is seen and the relationship between the
likely the loss of contact between the electrode and the uterine serosa is clear.
external sheath and the cervix. The most The use of electrodes with damaged
probable explanations are some combina- insulation should be avoided consequently,
tion of overdilation, or ‘‘externalization’’ a new electrode should be used for each
of the external sheath, a circumstance that case. It is probably safer to use low-voltage
may occur more often when the cervical (cutting) current, minimizing or avoiding
canal is short or when the surgeon func- high-voltage (coagulation) waveforms, as
tions by withdrawing the entire sheath such waveforms probably facilitate these
while keeping the activated electrode fully complications. Even with resectoscopic
extended84 (Fig. 3). electrodessication, it is apparent that both
low-voltage and high-voltage outputs are
RISK MINIMIZATION, RECOGNITION, equivalent with respect to clinical outcome,
MANAGEMENT evidence that should lead surgeons to con-
The following principles serve to reduce clude that modulated high-voltage wave-
the risk of electrosurgical injuries. First forms are unnecessary for intrauterine
and foremost, the pedals controlling the surgery.88 It is also important for the sur-
electrode should not be placed in a loca- geon to maintain intimate contact between
tion that facilitates inadvertent activation. the resectoscope’s external sheath and the
In addition, we recommend keeping the entire length of the cervical canal by avoid-
ESU in a standby mode until the resecto- ing overdilation before starting the proce-
scope is within the endometrial cavity and dure and by keeping the external sheath
ready for use. fully in the cervix when operating. The
Bipolar resectoscopes eliminate the risk electrode should be activated only when
of current diversion, and hyponatremia near or in contact with the target tissue, and
while allowing a larger fluid-deficit the temptation to overdesiccate the tissue
threshold for termination of the proce- should be avoided. All of these steps min-
dure. However, for those who use monop- imize the risk of making the resectoscope
olar instruments, a number of safety into a capacitor with the potential to divert
measures must be considered. current and induce thermal injury to the
The dispersive electrode required of vulva or vagina.84
monopolar systems should be securely One sign of current diversion is the
affixed to the patient, usually on the thigh, absence of/or reduction of the electrosur-
in a location that is not disrupted by gical effect. Following determination that
previous surgery, trauma, or prosthesis, power to the ESU and connections in the
such as a previous graft or burn site or a circuit are intact, the temptation is often
prosthetic hip. Most ESUs possess an to increase the generator output. Care
impedance-based safety mechanism, both should be taken to ensure that potentially
to ensure that the dispersive electrode is traumatic current diversion is not taking
attached to the generator, and to detect place.
partial detachment, but older systems Any metallic object, such as a vaginal
may not have this important safeguard. speculum or a cervical tenaculum, can
As described in the section on perforation, serve to conduct current to locations in
advancement of an activated electrode the vagina and vulva following contact
should be avoided when in the with the external sheath. Care should be
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 789
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
790 Munro and Christianson
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 791
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
792 Munro and Christianson
previous tubal occlusion. Synechiae with- ablation are at increased risk for cesarean
in the endometrial cavity can prevent or gravid hysterectomy secondary to sig-
efflux of blood through the cervix, where- nificant hemorrhage.112,113
as the occluded tubes prevent passage of
blood into the peritoneal cavity, resulting RISK REDUCTION
in cyclic pain associated with endometrial Women who choose to undergo endome-
bleeding.105 It is not clear if such a syn- trial ablation should be strongly cau-
drome could follow transcervical sterili- tioned regarding possible longer-term
zation with devices such as Essure (Bayer adverse events. Continuing with an effec-
Essure Inc., Pittsburg, PA) or the now tive contraceptive method until meno-
withdrawn Adiana (Hologic Inc.) occlu- pause or at least to the age of 50 can
sion system that, nevertheless, is posi- largely prevent the complications associ-
tioned in tens of thousands of women. ated with gestation in the setting of pre-
A number of hysteroscopic procedures vious endometrial ablation. Should a
are designed to treat infertility, recurrent pregnancy ensue in such a woman, she
pregnancy loss, or to manage uterine should be appropriately counseled re-
bleeding while maintaining fertility. In garding the risks of continuing the preg-
the event of a pregnancy, uterine rupture nancy, and should the pregnancy
is a potential consequence of these proce- continue and reach viability, appropriate
dures, particularly if hysteroscopic sur- investigation and planning should sur-
gery has substantially violated the round the delivery.
integrity of the myometrium. Uterine per- For women who have already had a
foration and resection using monopolar sterilization procedure, at least those with
resectoscopes are well-known risk factors ligation, clips, rings, or electrodessication,
for subsequent uterine rupture during counseling before endometrial ablation
pregnancy.106 One review of the literature should include discussion of cyclic pain
involving pregnancy-associated uterine as a potential long-term adverse event.
rupture posthysteroscopic surgery identi- When intrauterine surgery is performed
fied 12 of 14 cases that had occurred to preserve or enhance fertility, the risk of
following hysteroscopic metroplasty.107 formation of postsurgical uterine adhesions
Although uterine rupture is most likely should be considered. Proposed interven-
to occur in labor, spontaneous rupture as tions to reduce the risk or extent of adhesion
early as 22 weeks of gestational age has formation include systemic estrogens and
been reported after an uncomplicated intrauterine barriers ranging from intrauter-
hysteroscopic myomectomy.108 ine contraception systems (IUDs), to Foley
Endometrial ablation can never be con- catheter balloons, to absorbable mechanical
sidered to be a ‘‘global’’ therapy. As a barriers.114 Estrogen therapy alone has not
result, pregnancy can result in women in been found to consistently prevent intra-
the reproductive years, where only the uterine adhesion formation or to improve
minority has an uncomplicated course, reproductive outcomes; in a number of
at least according to a review of 74 re- studies better fertility outcomes were asso-
ported cases collated and published in ciated with use of estrogen in combination
2006.109 Disorders of placental implanta- with other prophylactic methods.115,116 A
tion have been reported including both systematic review of 5 trials concluded that
placenta accreta and increta and a case of the use of an antiadhesion barrier gel is
uterine rupture resulted in a maternal associated with a decreased incidence of
death.110–112 Not surprisingly, available de novo intrauterine adhesions; however,
case reports suggest that pregnancies this did not translate to an increase in live
complicated by a history of endometrial birth rate.117 Another study comparing
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 793
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
794 Munro and Christianson
17. Berde CB. Toxicity of local anesthetics in infants 30. Istre O, Bjoennes J, Naess R, et al. Postoperative
and children. J Pediatr. 1993;122(5 pt cerebral oedema after transcervical endometrial
2):S14–S20. resection and uterine irrigation with 1.5% gly-
18. American College of Obstetricians and Gynecol- cine. Lancet. 1994;344:1187–1189.
ogists. Technology assessment no. 7: hystero- 31. Nezhat CH, Fisher DT, Datta S. Investigation of
scopy. Obstet Gynecol. 2011;117:1486–1491. often-reported ten percent hysteroscopy fluid
19. Thomas JA, Leyland N, Durand N, et al. The use overfill: is this accurate? J Minim Invasive Gyne-
of oral misoprostol as a cervical ripening agent in col. 2007;14:489–493.
operative hysteroscopy: a double-blind, placebo- 32. Bennett KL, Ohrmundt C, Maloni JA. Prevent-
controlled trial. Am J Obstet Gynecol. ing intravasation in women undergoing hystero-
2002;186:876–879. scopic procedures. AORN J. 1996;64:792–799.
20. Preutthipan S, Herabutya Y. Vaginal misopros- 33. Pellicano M, Guida M, Zullo F, et al. Carbon
tol for cervical priming before operative hystero- dioxide versus normal saline as a uterine disten-
scopy: a randomized controlled trial. Obstet sion medium for diagnostic vaginoscopic hys-
Gynecol. 2000;96:890–894. teroscopy in infertile patients: a prospective,
21. Polyzos NP, Zavos A, Valachis A, et al. Miso- randomized, multicenter study. Fertil Steril.
prostol prior to hysteroscopy in premenopausal 2003;79:418–421.
and post-menopausal women. A systematic re- 34. Brusco GF, Arena S, Angelini A. Use of carbon
view and meta-analysis. Hum Reprod Update. dioxide versus normal saline for diagnostic hys-
2012;18:393–404. teroscopy. Fertil Steril. 2003;79:993–997.
22. Mulayim B, Celik NY, Onalan G, et al. Sub- 35. Golan A, Siedner M, Bahar M, et al. High-
lingual misoprostol for cervical ripening before output left ventricular failure after dextran use
diagnostic hysteroscopy in premenopausal in an operative hysteroscopy. Fertil Steril. 1990;
women: a randomized, double blind, placebo- 54:939–941.
controlled trial. Fertil Steril. 2010;93:2400–2404.
36. Choban MJ, Kalhan SB, Anderson RJ, et al.
23. Oppegaard KS, Nesheim BI, Istre O, et al. Com-
Pulmonary edema and coagulopathy following
parison of self-administered vaginal misoprostol
intrauterine instillation of 32% dextran-70 (Hys-
versus placebo for cervical ripening prior to
kon). J Clin Anesth. 1991;3:317–319.
operative hysteroscopy using a sequential trial
37. Worldwide AAMIG, Munro MG, Storz K, Ab-
design. BJOG. 2008;115:663e1–663e9.
bott JA, et al. AAGL Practice Report: Practice
24. Oppegaard KS, Lieng M, Berg A, et al. A
Guidelines for the Management of Hystero-
combination of misoprostol and estradiol for
scopic Distending Media: (Replaces Hystero-
preoperative cervical ripening in postmeno-
scopic Fluid Monitoring Guidelines. J Am
pausal women: a randomised controlled trial.
BJOG. 2010;117:53–61. Assoc Gynecol Laparosc. 2000;7:167-168.).
25. Kale A, Terzi H, Kale E. Sublingual misoprostol J Minim Invasive Gynecol. 2013;20:137–148.
is better for cervical ripening prior to hystero- 38. Wegmuller B, Hug K, Meier Buenzli C, et al.
scopy in post-menopausal women. Clin Exp Life-threatening laryngeal edema and hypona-
Obstet Gynecol. 2014;41:402–404. tremia during hysteroscopy. Crit Care Res Pract.
26. Tanha FD, Salimi S, Ghajarzadeh M. Sublin- 2011;2011:140381.
gual versus vaginal misoprostol for cervical rip- 39. Taskin O, Buhur A, Birincioglu M, et al. Endo-
ening before hysteroscopy: a randomized clinical metrial Na+ , K+ -ATPase pump function and
trial. Arch Gynecol Obstet. 2013;287:937–940. vasopressin levels during hysteroscopic surgery
27. Inal HA, Ozturk Inal ZH, Tonguc E, et al. in patients pretreated with GnRH agonist. J Am
Comparison of vaginal misoprostol and dino- Assoc Gynecol Laparosc. 1998;5:119–124.
prostone for cervical ripening before diagnostic 40. Ayus JC, Wheeler JM, Arieff AI. Postoperative
hysteroscopy in nulliparous women. Fertil Steril. hyponatremic encephalopathy in menstruant
2015;103:1326–1331. women. Ann Intern Med. 1992;117:891–897.
28. Phillips DR, Nathanson HG, Milim SJ, et al. 41. Baggish MS, Brill AI, Rosenweig B, et al. Fatal
The effect of dilute vasopressin solution on the acute glycine and sorbitol toxicity during oper-
force needed for cervical dilatation: a random- ative hysteroscopy. J Gynecol Surg. 1998;9:
ized controlled trial. Obstet Gynecol. 1997;89: 137–143.
507–511. 42. Bernstein GT, Loughlin KR, Gittes RF. The
29. Istre O, Skajaa K, Schjoensby AP, et al. Changes physiologic basis of the TUR syndrome. J Surg
in serum electrolytes after transcervical resection Res. 1989;46:135–141.
of endometrium and submucous fibroids with 43. Park JT, Lim HK, Kim SG, et al. A comparison
use of glycine 1.5% for uterine irrigation. Obstet of the influence of 2.7% sorbitol-0.54% manni-
Gynecol. 1992;80:218–222. tol and 5% glucose irrigating fluids on plasma
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 795
serum physiology during hysteroscopic proce- of paradoxical air embolism. Am J Obstet Gyne-
dures. Korean J Anesthesiol. 2011;61:394–398. col. 1959;78:96–99.
44. Shirk GJ, Gimpelson RJ. Control of intrauterine 57. Corson SL, Brooks PG, Soderstrom RM. Gy-
fluid pressure during operative hysteroscopy. necologic endoscopic gas embolism. Fertil Steril.
J Am Assoc Gynecol Laparosc. 1994;1:229–233. 1996;65:529–533.
45. Boyd HR, Stanley C. Sources of error when 58. Perry PM, Baughman VL. A complication of
tracking irrigation fluids during hysteroscopic hysteroscopy: air embolism. Anesthesiology.
procedures. J Am Assoc Gynecol Laparosc. 2000; 1990;73:546–547.
7:472–476. 59. Brooks PG. Venous air embolism during oper-
46. Kumar A, Kumar A. New hysteroscopy pump to ative hysteroscopy. J Am Assoc Gynecol Lapa-
monitor real-time rate of fluid intravasation. rosc. 1997;4:399–402.
J Minim Invasive Gynecol. 2012;19:369–375. 60. Baggish MS, Daniell JF. Death caused by air
47. Emanuel MH, Hart A, Wamsteker K, et al. An embolism associated with neodymium:yttrium-
analysis of fluid loss during transcervical resec- aluminum-garnet laser surgery and artificial sap-
tion of submucous myomas. Fertil Steril. 1997; phire tips. Am J Obstet Gynecol. 1989;161:
68:881–886. 877–878.
48. Donnez J, Vilos G, Gannon MJ, et al. Goserelin 61. Nachum Z, Kol S, Adir Y, et al. Massive air
acetate (Zoladex) plus endometrial ablation for embolism—a possible cause of death after oper-
dysfunctional uterine bleeding: a large random- ative hysteroscopy using a 32% dextran-70
ized, double-blind study. Fertil Steril. 1997;68: pump. Fertil Steril. 1992;58:836–838.
29–36. 62. Groenman FA, Peters LW, Rademaker BM,
49. Mavrelos D, Ben-Nagi J, Davies A, et al. The et al. Embolism of air and gas in hysteroscopic
value of pre-operative treatment with GnRH procedures: pathophysiology and implication
analogues in women with submucous fibroids: for daily practice. J Minim Invasive Gynecol.
a double-blind, placebo-controlled randomized 2008;15:241–247.
trial. Hum Reprod. 2010;25:2264–2269. 63. Brandner P, Neis KJ, Ehmer C. The etiology,
50. Goldenberg M, Zolti M, Bider D, et al. The effect frequency, and prevention of gas embolism dur-
of intracervical vasopressin on the systemic ab- ing CO(2) hysteroscopy. J Am Assoc Gynecol
sorption of glycine during hysteroscopic endo- Laparosc. 1999;6:421–428.
metrial ablation. Obstet Gynecol. 1996;87: 64. Obenhaus T, Maurer W. CO2 embolism during
1025–1029. hysteroscopy. Anaesthesist. 1990;39:243–246.
51. Phillips DR, Nathanson HG, Milim SJ, et al. 65. Vo Van JM, Nguyen NQ, Le Bervet JY. A fatal
The effect of dilute vasopressin solution on gas embolism during a hysteroscopy-curettage.
blood loss during operative hysteroscopy: a Cah Anesthesiol. 1992;40:617–618.
randomized controlled trial. Obstet Gynecol. 66. Stoloff DR, Isenberg RA, Brill AI. Venous air
1996;88:761–766. and gas emboli in operative hysteroscopy. J Am
52. Corson SL, Brooks PG, Serden SP, et al. Effects Assoc Gynecol Laparosc. 2001;8:181–192.
of vasopressin administration during hystero- 67. Leibowitz D, Benshalom N, Kaganov Y, et al.
scopic surgery. J Reprod Med. 1994;39:419–423. The incidence and haemodynamic significance
53. Vercellini P, Oldani S, Yaylayan L, et al. of gas emboli during operative hysteroscopy: a
Randomized comparison of vaporizing elec- prospective echocardiographic study. Eur J
trode and cutting loop for endometrial ablation. Echocardiogr. 2010;11:429–431.
Obstet Gynecol. 1999;94:521–527. 68. Munro MG, Weisberg M, Rubinstein E. Gas
54. Vercellini P, Oldani S, DeGiorgi O, et al. Endo- and air embolization during hysteroscopic elec-
metrial ablation with a vaporizing electrode in trosurgical vaporization: comparison of gas gen-
women with regular uterine cavity or submucous eration using bipolar and monopolar electrodes
leiomyomas. J Am Assoc Gynecol Laparosc. in an experimental model. J Am Assoc Gynecol
1996;3(suppl):S52. Laparosc. 2001;8:488–494.
55. Munro MG, Storz K, Abbott JA, et al. AAGL 69. Munro MG, Brill AI, Ryan T, et al. Electro-
Practice Report: Practice Guidelines for the surgery-induced generation of gases: compari-
Management of Hysteroscopic Distending Me- son of in vitro rates of production using bipolar
dia: (Replaces Hysteroscopic Fluid Monitoring and monopolar electrodes. J Am Assoc Gynecol
Guidelines. J Am Assoc Gynecol Laparosc. Laparosc. 2003;10:252–259.
2000;7:167-168.). J Minim Invasive Gynecol. 70. Rademaker BM, van Kesteren PJ, de Haan P,
2013;20:137–148. et al. How safe is the intravasation limit in
56. Karandy EJ, Dick HJ, Dwyer RP, et al. Fatal air hysteroscopic surgery? J Minim Invasive Gyne-
embolism; a report of two cases, including a case col. 2011;18:355–361.
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
796 Munro and Christianson
71. Karuparthy VR, Downing JW, Husain FJ, et al. States and Canada. J Am Assoc Gynecol Lapa-
Incidence of venous air embolism during cesar- rosc. 2000;7:141–147.
ean section is unchanged by the use of a 5 to 10 86. Vilos GA, Newton DW, Odell RC, et al. Charac-
degree head-up tilt. Anesth Analg. 1989;69: terization and mitigation of stray radiofrequency
620–623. currents during monopolar resectoscopic electro-
72. Handler JS, Bromage PR. Venous air embolism surgery. J Minim Invasive Gynecol. 2006;13:
during cesarean delivery. Reg Anesth. 1990;15: 134–140.
170–173. 87. Munro MG. Factors affecting capacitive current
73. Durant TM, Long J, Oppenheimer J. Pulmonary diversion with a uterine resectoscope: an in vitro
venous embolism. Am Heart J. 1947;33:269–281. study. J Am Assoc Gynecol Laparosc. 2003;10:
74. Truhlar A, Cerny V, Dostal P, et al. Out-of- 450–460.
hospital cardiac arrest from air embolism during 88. Chang PT, Vilos GA, Abu-Rafea B, et al. Com-
sexual intercourse: case report and review of the parison of clinical outcomes with low-voltage
literature. Resuscitation. 2007;73:475–484. (cut) versus high-voltage (coag) waveforms dur-
75. Kayatas S, Meseci E, Tosun OA, et al. Experi- ing hysteroscopic endometrial ablation with the
ence of hysteroscopy indications and complica- rollerball: a pilot study. J Minim Invasive Gyne-
tions in 5,474 cases. Clin Exp Obstet Gynecol. col. 2009;16:350–353.
2014;41:451–454. 89. Haber K, Hawkins E, Levie M, et al. Hystero-
76. Sullivan B, Kenney P, Seibel M. Hysteroscopic scopic morcellation: review of the Manufacturer
resection of fibroid with thermal injury to sig- and User Facility Device Experience (MAUDE)
moid. Obstet Gynecol. 1992;80(3 pt 2):546–547. Database. J Minim Invasive Gynecol. 2015;22:
77. Castaing N, Darai E, Chuong T, et al. Mech- 110–114.
anical and metabolic complications of hystero- 90. Emanuel MH, Wamsteker K. The Intra Uterine
scopic surgery: report of a retrospective study of Morcellator: a new hysteroscopic operating
352 procedures. Contracept Fertil Sex. 1999; technique to remove intrauterine polyps and
27:210–215. myomas. J Minim Invasive Gynecol. 2005;12:
78. Lee KC, Kim HY, Lee MJ, et al. Abdominal 62–66.
compartment syndrome occurring due to uterine 91. Cohen S, Greenberg JA. Hysteroscopic morcel-
perforation during a hysteroscopy procedure. lation for treating intrauterine pathology. Rev
J Anesth. 2010;24:280–283. Obstet Gynecol. 2011;4:73–80.
79. Kresowik JD, Syrop CH, Van Voorhis BJ, et al. 92. Rovira Pampalona J, Degollada Bastos M,
Ultrasound is the optimal choice for guidance in Mancebo Moreno G, et al. Outpatient Hystero-
difficult hysteroscopy. Ultrasound Obstet Gyne- scopic Polypectomy: Bipolar Energy System
col. 2012;39:715–718. (Versapoint(R)) versus Mechanical Energy Sys-
80. Agostini A, Cravello L, Desbriere R, et al. Hem- tem (Truclear System(R))—preliminary results.
orrhage risk during operative hysteroscopy. Ac- Gynecol Obstet Invest. 2015;80:3–9.
ta Obstet Gynecol Scand. 2002;81:878–881. 93. Noventa M, Ancona E, Quaranta M, et al. Intra-
81. Erdas E, Dazzi C, Secchi F, et al. Incidence and uterine morcellator devices: the icon of hystero-
risk factors for trocar site hernia following lap- scopic future or merely a marketing image? A
aroscopic cholecystectomy: a long-term follow- systematic review regarding safety, efficacy, ad-
up study. Hernia. 2012;16:431–437. vantages, and contraindications. Reprod Sci.
82. Mencaglia L, Carri G, Prasciolu C, et al. Feasi- 2015. [Epub ahead of print].
bility and complications in bipolar resectoscopy: 94. van Dongen H, Emanuel MH, Wolterbeek R,
preliminary experience. Minim Invasive Ther Al- et al. Hysteroscopic morcellator for removal of
lied Technol. 2013;22:50–55. intrauterine polyps and myomas: a randomized
83. Litta P, Leggieri C, Conte L, et al. Monopolar controlled pilot study among residents in train-
versus bipolar device: safety, feasibility, limits ing. J Minim Invasive Gynecol. 2008;15:466–471.
and perioperative complications in performing 95. Cicinelli E, Tinelli R, Colafiglio G, et al. Risk of
hysteroscopic myomectomy. Clin Exp Obstet long-term pelvic recurrences after fluid minihys-
Gynecol. 2014;41:335–338. teroscopy in women with endometrial carcino-
84. Munro MG. Mechanisms of thermal injury to ma: a controlled randomized study. Menopause.
the lower genital tract with radiofrequency re- 2010;17:511–515.
sectoscopic surgery. J Minim Invasive Gynecol. 96. Agostini A, Cravello L, Shojai R, et al. Post-
2006;13:36–42. operative infection and surgical hysteroscopy.
85. Vilos GA, Brown S, Graham G, et al. Genital Fertil Steril. 2002;77:766–768.
tract electrical burns during hysteroscopic endo- 97. Kasius JC, Broekmans FJ, Fauser BC, et al.
metrial ablation: report of 13 cases in the United Antibiotic prophylaxis for hysteroscopy
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Complications of Hysteroscopic Surgery 797
evaluation of the uterine cavity. Fertil Steril. 109. Lo JS, Pickersgill A. Pregnancy after endome-
2011;95:792–794. trial ablation: English literature review and case
98. Lockwood CJ, Nemerson Y, Guller S, et al. report. J Minim Invasive Gynecol. 2006;13:
Progestational regulation of human endometrial 88–91.
stromal cell tissue factor expression during de- 110. Patni S, ElGarib AM, Majd HS, et al. Endome-
cidualization. J Clin Endocrinol Metab. 1993;76: trial resection mandates reliable contraception
231–236. thereafter—a case report of placenta increta
99. McCausland VM, Fields GA, McCausland AM, following endometrial ablation. Eur J Contra-
et al. Tuboovarian abscesses after operative cept Reprod Health Care. 2008;13:208–211.
hysteroscopy. J Reprod Med. 1993;38:198–200. 111. Laberge PY. Serious and deadly complications
100. Bhattacharya S, Parkin DE, Reid TM, et al. A from pregnancy after endometrial ablation: two
prospective randomised study of the effects of
case reports and review of the literature. J Gyne-
prophylactic antibiotics on the incidence of bac-
col Obstet Biol Reprod (Paris). 2008;37:609–613.
teraemia following hysteroscopic surgery. Eur J
112. Roux I, Das M, Fernandez H, et al. Pregnancy
Obstet Gynecol Reprod Biol. 1995;63:37–40.
after endometrial ablation. A report of three
101. Thinkhamrop J, Laopaiboon M, Lumbiganon
P. Prophylactic antibiotics for transcervical in- cases. J Reprod Med. 2013;58:173–176.
trauterine procedures. Cochrane Database Syst 113. Holt R, Santiago-Munoz P, Nelson DB, et al.
Rev. 2013;5:CD005637. Sonographic findings in two cases of compli-
102. Thinkhamrop J, Laopaiboon M, Lumbiganon cated pregnancy in women previously treated
P. Prophylactic antibiotics for transcervical in- with endometrial ablation. J Clin Ultrasound.
trauterine procedures. Cochrane Database Syst 2013;41:566–569.
Rev. 2007;3:CD005637. 114. Fuchs N, Smorgick N, Ben Ami I, et al. Intercoat
103. Nappi L, Di Spiezio Sardo A, Spinelli M, et al. A (Oxiplex/AP gel) for preventing intrauterine ad-
multicenter, double-blind, randomized, placebo- hesions after operative hysteroscopy for sus-
controlled study to assess whether antibiotic pected retained products of conception:
administration should be recommended during double-blind, prospective, randomized pilot
office operative hysteroscopy. Reprod Sci. 2013; study. J Minim Invasive Gynecol. 2014;21:
20:755–761. 126–130.
104. American College of Obstetricians and Gynecol- 115. Roy KK, Negi N, Subbaiah M, et al. Effective-
ogists. Practice Bulletin No. 104: antibiotic pro- ness of estrogen in the prevention of intrauterine
phylaxis for gynecologic procedures. Obstet adhesions after hysteroscopic septal resection: a
Gynecol. 2009;113:1180–1189 prospective, randomized study. J Obstet Gynae-
105. Townsend DE, McCausland V, McCausland A, col Res. 2014;40:1085–1088.
et al. Post-ablation-tubal sterilization syndrome.
116. Johary J, Xue M, Zhu X, et al. Efficacy of
Obstet Gynecol. 1993;82:422–424.
estrogen therapy in patients with intrauterine
106. Ergenoglu M, Yeniel AO, Yildirim N, et al.
adhesions: systematic review. J Minim Invasive
Recurrent uterine rupture after hysterescopic
Gynecol. 2014;21:44–54.
resection of the uterine septum. Int J Surg Case
Rep. 2013;4:182–184. 117. Bosteels J, Weyers S, Mol BW, et al. Anti-
107. Sentilhes L, Sergent F, Roman H, et al. Late adhesion barrier gels following operative hys-
complications of operative hysteroscopy: pre- teroscopy for treating female infertility: a sys-
dicting patients at risk of uterine rupture during tematic review and meta-analysis. Gynecol Surg.
subsequent pregnancy. Eur J Obstet Gynecol 2014;11:113–127.
Reprod Biol. 2005;120:134–138. 118. Chappell N, Bates GW, McLaren JF. Repro-
108. Badial G, Fagan PJ, Masood M, et al. Sponta- ductive outcomes after operative hysteroscopy
neous uterine rupture at 22 weeks’ gestation in a using sodium hyaluronate and carboxymethyl-
multipara with previous hysteroscopic resection cellulose. Obstet Gynecol. 2014;123(suppl 1):
of fibroid. BMJ Case Rep. 2012;2012:1–4. 188S.
www.clinicalobgyn.com
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.